THE SPANISH CNMC HAS INITIATED PROCEEDINGS AGAINST PFIZER
The CNMC, the Spanish Competition Authority, has initiated proceedings against Pfizer for a potential anticompetitive conduct derived from the supply contracts. The referred company signed the contracts with several wholesale distributors. Such supply contracts are deemed to impede effective parallel commerce within the European Union. In 2005, Spain Pharma filed a claim against Pfizer and…